Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
Clinical trial NCT05789303 · RECRUITING
Trial details
- NCT number
- NCT05789303
- Sponsor
- University of Chicago
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-30
- Primary completion
- 2028-07-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.